Breast Cancer Medicine: Today and Tomorrow

VIDEO | 33:00

Larry Norton, Deputy Physician-in-Chief for Breast Cancer Programs at Memorial Sloan Kettering Cancer Center, explains how new information about the biology of breast cancer is paving the way for a more targeted approach to chemotherapy to treatment. Advances in the field of molecular genetics have shown that breast cancer can be caused by several genetic mutations. Researchers are using this information to develop more-effective therapies that target these genes.